FDA Ends Centralized Entry Review Pilot Early Due to Shutdown
The Food and Drug Administration ended its Centralized Entry Review Pilot on Sept. 30 as a result of the partial government shutdown, said CBP in a CSMS message. The pilot, which is hoped to help improve efficiency of document reviews…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
by centralizing the agency's entry review resources, was originally scheduled to continue through Nov. 2 (see 13061915).